174 related articles for article (PubMed ID: 12226062)
1. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease.
Okumura H; Nagaya N; Kyotani S; Sakamaki F; Nakanishi N; Fukuhara S; Yutani C
Chest; 2002 Sep; 122(3):1096-8. PubMed ID: 12226062
[TBL] [Abstract][Full Text] [Related]
2. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease.
Palmer SM; Robinson LJ; Wang A; Gossage JR; Bashore T; Tapson VF
Chest; 1998 Jan; 113(1):237-40. PubMed ID: 9440597
[TBL] [Abstract][Full Text] [Related]
3. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.
Montani D; Jaïs X; Price LC; Achouh L; Degano B; Mercier O; Mussot S; Fadel E; Dartevelle P; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2009 Dec; 34(6):1348-56. PubMed ID: 19541723
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease.
Davis LL; deBoisblanc BP; Glynn CE; Ramirez C; Summer WR
Chest; 1995 Dec; 108(6):1754-6. PubMed ID: 7497799
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Wax D; Garofano R; Barst RJ
Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Yamadori I; Shinno Y; Miura A; Kusano KF; Ito H; Date H; Matsubara H
Circ J; 2012; 76(7):1729-36. PubMed ID: 22481098
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Matsubara H
Respir Med; 2017 Oct; 131():215-219. PubMed ID: 28947033
[TBL] [Abstract][Full Text] [Related]
10. Resolution of pulmonary hypertension with low-molecular-weight heparin, steroid, and prostacyclin analogue therapy: could it be early-phase pulmonary veno-occlusive disease?
Yildirim ZK; Sepetcigil O; Karacan M; Kantarci M; Buyukavci M
Pediatr Hematol Oncol; 2011 Sep; 28(6):529-34. PubMed ID: 21707224
[TBL] [Abstract][Full Text] [Related]
11. Sudden Death in a Patient with Pulmonary Veno-occlusive Disease (PVOD) and Severe Pulmonary Hypertension.
Saito M; Ohshima N; Matsui H; Hebisawa A; Ohta K
Intern Med; 2017; 56(15):2025-2031. PubMed ID: 28768975
[TBL] [Abstract][Full Text] [Related]
12. A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.
Sourla E; Paspala A; Boutou A; Kontou P; Stanopoulos I; Pitsiou G
Ther Adv Respir Dis; 2013 Apr; 7(2):119-23. PubMed ID: 23235992
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease.
Sato H; Sugimura K; Miura M; Konno R; Kozu K; Yaoita N; Shimizu T; Yamamoto S; Aoki T; Tatebe S; Satoh K; Shimokawa H
Tohoku J Exp Med; 2019 Feb; 247(2):69-73. PubMed ID: 30700638
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
Luo Q; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Zhang Y; Xiong C; Liu Z
BMC Pulm Med; 2019 Dec; 19(1):257. PubMed ID: 31856792
[TBL] [Abstract][Full Text] [Related]
15. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
16. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
Miura A; Akagi S; Nakamura K; Ohta-Ogo K; Hashimoto K; Nagase S; Kohno K; Kusano K; Ogawa A; Matsubara H; Toyooka S; Oto T; Ohtsuka A; Ohe T; Ito H
Cardiovasc Pathol; 2013; 22(4):287-93. PubMed ID: 23312620
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and survival of patients with pulmonary veno-occlusive disease].
Jiang X; Chen FD; He J; Jiang R; Di RM; Zhao QH; Jing ZC
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):896-900. PubMed ID: 22321271
[TBL] [Abstract][Full Text] [Related]
19. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease.
Seferian A; Helal B; Jaïs X; Girerd B; Price LC; Günther S; Savale L; Dorfmüller P; Parent F; Sitbon O; Humbert M; Simonneau G; Montani D
Eur Respir J; 2012 Jul; 40(1):75-83. PubMed ID: 22088969
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.
Masters K; Bennett S
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23378546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
